News

Tate Hermanson

Tate manages accounting and finance for RheumaGen. He has 20 years of experience overseeing financial and accounting aspects of cell and gene therapy development. He specializes in managing finances and accounting for healthcare related businesses, helping them make efficient use of capital to achieve the best outcomes for patients. In addition to his work at RheumaGen, Tate is also the Director of Finance for the Department of Medicine at the University of Colorado. Tate oversees the finances of all seventeen divisions within the Department, whose clinical specialties bill ~$300M per year, and he is responsible for negotiating direct hospital contracts that total ~$50M per year.